635712-89-9 Usage
Uses
Used in Pharmaceutical Industry:
4,5,6,7-Tetrahydro-7,7-dimethyl-1H-pyrazolo[4,3-c]pyridine hydrochloride is used as a building block for the synthesis of drugs. Its complex molecular structure and potential reactivity make it a valuable component in the development of new pharmaceutical compounds.
Used in Pesticide Production:
In the agricultural sector, 4,5,6,7-tetrahydro-7,7-dimethyl-1H-pyrazolo[4,3-c]pyridine hydrochloride is used as a key component in the formulation of pesticides. Its chemical properties allow for the creation of effective pest control agents, contributing to crop protection and yield enhancement.
Used in Chemical Research:
4,5,6,7-Tetrahydro-7,7-dimethyl-1H-pyrazolo[4,3-c]pyridine hydrochloride is employed as a research compound in various chemical studies. Its unique structure and reactivity make it an interesting subject for exploration in academic and industrial research settings, potentially leading to new discoveries and applications.
Check Digit Verification of cas no
The CAS Registry Mumber 635712-89-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,3,5,7,1 and 2 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 635712-89:
(8*6)+(7*3)+(6*5)+(5*7)+(4*1)+(3*2)+(2*8)+(1*9)=169
169 % 10 = 9
So 635712-89-9 is a valid CAS Registry Number.
InChI:InChI=1/C8H13N3.ClH/c1-8(2)5-9-3-6-4-10-11-7(6)8;/h4,9H,3,5H2,1-2H3,(H,10,11);1H
635712-89-9Relevant academic research and scientific papers
Calcitonin gene related peptide receptor antagonists
-
, (2008/06/13)
The present invention relates to compounds of Formula (I) as antagonists of calcitonin gene-related peptide receptors (“CGRP-receptor”), pharmaceutical compositions comprising them, methods for identifying them, methods of treatment using them and their use in therapy for treatment of neurogenic vasodilation, neurogenic inflammation, migraine and other headaches, thermal injury, circulatory shock, flushing associated with menopause, airway inflammatory diseases, such as asthma and chronic obstructive pulmonary disease (COPD), and other conditions the treatment of which can be effected by the antagonism of CGRP-receptors.
CALCITONIN GENE RELATED PEPTIDE RECEPTOR ANTAGONISTS
-
Page 159, (2010/02/04)
The presnt invention relates to compounds of Formula (I), as antagonists of calcitonin gene-related peptide receptors ("CGRP-receptor"), pharmaceutical compositions comprising them, methods for identifying them, methods of treatment using them and their use in therapy for treatment of neurogenic vasodilation, neurogenic inflammation, migraine and other headaches, thermal injury, circulatory shock, flushing associated with menopause, airway inflammatory diseases, such as asthma and chronic obstructive pulmonary disease (COPD), and other conditions the treatment of which can be effected by the antagonism of CGRP-receptors.
